Corin Group is a pioneer in the field of orthopaedic innovation, dedicated to enhancing patient well-being through its proven implants, connected technologies, and data. Since its establishment in 1985, the company has spearheaded numerous groundbreaking developments, positively impacting the lives of patients worldwide. With a strong commitment to exceeding expectations, Corin's talented teams deliver quality orthopaedic products and services to patients, surgeons, and healthcare providers. Their last investment was a Private Equity Round led by Permira on 11 May 2018. Corin Group operates in the Health Care, Manufacturing, and Medical Devices industries from its headquarters in the United Kingdom. Recognizing the growing need for state-of-the-art treatment pathways, the company's product portfolio is designed to provide each patient with the most advanced solutions, utilizing cutting-edge technologies to enhance implant longevity and performance. In summary, Corin Group's dedication to innovation and commitment to improving patient outcomes make it an attractive prospect for investment within the orthopaedic sector, especially with its track record of pioneering advancements and the recent support from Permira in 2018.
No recent news or press coverage available for Corin Group.